Accent Therapeutics, Inc.  logo

Accent Therapeutics, Inc.

Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer

55 employees · est. 2017 · Lexington, United States

VS
Asimov logo

Asimov

Intelligent design of living systems

119 employees · est. 2017 · Boston, United States

Side-by-Side Comparison

Accent Therapeutics, Inc. Asimov
Founded
2017 2017
Headquarters
Lexington, United States Boston, United States
Employees
55 119
Industry
Biotechnology, Health and Wellness, Pharmaceutical AI, Biotechnology, Health and Wellness
Funding Stage
Series C Series B
Total Funding
$178.00M $204.70M
Funding Rounds
3 4
Services
Not tracked yet end-to-end genetic design platform, cell line development, gene and RNA therapy production, biological tools and computational models, lab-in-the-loop platform, design and manufacturing integration
Target Customers
Not tracked yet biotech companies, pharmaceutical companies, synthetic biologists, research institutions, healthcare innovators, biotherapeutics developers
Taxonomy
RNA-modifying Protein, RMP Biology, Cancer Therapies, Chemical Biology Platform, Target Identification, Drug Development, Small Molecule Therapies Intelligent Design, Living Systems, Synthetic Biology, Mammalian Biology, Computer-Aided Design, Biologics Manufacturing, Gene Therapies, Cell Programming, Biotech Innovation, Bioengineering, Life Sciences, Cell Engineering
Website
accenttx.com asimov.com
Accent Therapeutics, Inc.  logo

About Accent Therapeutics, Inc.

Accent Therapeutics, Inc. is a biotechnology and pharmaceutical company founded in 2017 and headquartered in the United States. The company is dedicated to leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer. With a robust chemical biology platform...

Asimov logo

About Asimov

Asimov is at the forefront of bioengineering, propelling the AI, Biotechnology, and Health and Wellness industries with its innovative approach to cellular programming. Founded in 2017, the company harnesses the synergies of mammalian synthetic biology, computer-aided design, and machine learning. T...

We will tell you when either one moves

BounceWatch watches Accent Therapeutics, Inc. and Asimov for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Accent Therapeutics, I... and Asimov — by email.

Frequently Asked Questions

Accent Therapeutics, Inc. — Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer. Asimov — Intelligent design of living systems. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Accent Therapeutics, Inc. has raised $178.00M while Asimov has raised $204.70M.
Accent Therapeutics, Inc. and Asimov operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Accent Therapeutics, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Accent Therapeutics, Inc. on 12 Sep 2024, and Asimov on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy